ArticleOpen veterinary journal2025
Evaluation of a commercial real-time polymerase chain reaction kit for the detection of avian orthoavulavirus type I.
Article in Open veterinary journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Newcastle disease (ND) is a highly contagious and often fatal viral disease that affects a wide range of avian species, regardless of age or sex. It continues to represent a significant challenge to the productivity and survival of both commercial and traditional poultry, particularly in developing countries. Despite advancements in vaccination strategies, ND outbreaks remain a recurring issue in many areas, including Morocco. Early detection of Newcastle Disease Virus (NDV) is critical for effective disease management, but conventional virus isolation methods are labor-intensive and time-consuming. Aim: This study aimed to evaluate and validate the performance of the ID Gene™ Newcastle Disease Duplex real-time RT-PCR kit for the rapid and sensitive detection of NDV in poultry samples. The validation was performed in accordance with international OIE standards to ensure reliability and applicability in veterinary diagnostics. Methods: The study utilized spiked biological samples and NDV strains, including Moroccan field strains and reference strains from the Isntituto Zooprofilattico Sperimentale delle Venezie proficiency panel. RNA extraction was performed using the NucleoSpin® RNA Virus kit. Negative tracheal and cloacal swab supernatants, as well as homogenized tissue samples from the liver and lungs, were spiked with JEL/Morocco Newcastle virus, genotype VI at different concentrations. Real-time RT-PCR targeting the NDV M gene was performed with an exogenous internal control for duplex amplification. The analytical specificity was assessed for inclusivity with various NDV genotypes and exclusivity against other orthomyxoviruses. Sensitivity was determined using 10-fold serial dilutions of NDV, with detection limits evaluated for individual and pooled samples. Repeatability was assessed by calculating intra-assay and inter-assay coefficients of variation based on Ct values. Results: The ID Gene™ kit demonstrated excellent inclusivity and reliably detected all tested NDV strains irrespective of genotype while showing no cross-reactivity with non-NDV orthomyxoviruses. The analytical sensitivity was validated at 10 Conclusion: The ID Gene™ Newcastle Disease Duplex Kit is a rapid, accurate, and sensitive diagnostic alternative to traditional virus isolation methods. The performance of this method, validated against international and national standards, highlights its potential as a reliable tool for the early detection and effective management of NDV infections in Moroccan poultry populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.